These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug action--study of plasma protein variations in hyperthrombotic diseases using gel filtration chromatography on agarose. Morelli AC; Pollini H; Del Pino MC Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):259-68. PubMed ID: 5357865 [No Abstract] [Full Text] [Related]
3. Should factor XII assays be included in thrombophilia screening? Winter M; Gallimore M; Jones DW Lancet; 1995 Jul; 346(8966):52. PubMed ID: 7603161 [No Abstract] [Full Text] [Related]
4. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait. Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563 [TBL] [Abstract][Full Text] [Related]
5. Hageman factor (factor XII) in health and diseases. Saito H Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1460-5. PubMed ID: 7342648 [No Abstract] [Full Text] [Related]
6. Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat. Latour JG; Léger C; Renaud S Am J Pathol; 1974 Aug; 76(2):179-94. PubMed ID: 4843381 [TBL] [Abstract][Full Text] [Related]
7. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic. Takeishi M; Mimori A; Nakajima K; Mimura T; Suzuki T Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317 [TBL] [Abstract][Full Text] [Related]
8. [Factor XII (Hageman factor)]. Saito H Nihon Rinsho; 1995 Mar; 53 Su Pt 2():87-9. PubMed ID: 8753188 [No Abstract] [Full Text] [Related]
13. [Chromatographic method of analyzing Hageman factor (blood coagulation factor XII) in human serum]. Krizhevskaia IuV; Dotsenko VL; Iarovaia GA Vopr Med Khim; 1982; 28(2):128-32. PubMed ID: 7080474 [No Abstract] [Full Text] [Related]
14. Factor XII (Hageman) levels in women with recurrent pregnancy loss. Ozgu-Erdinc AS; Togrul C; Aktulay A; Buyukkagnici U; Yapar Eyi EG; Erkaya S J Pregnancy; 2014; 2014():459192. PubMed ID: 25436153 [TBL] [Abstract][Full Text] [Related]
15. [The Hageman factor and its active forms. Separation, methods of determination and its characteristics]. Simonianová E; Rybák M Cesk Farm; 1986 Apr; 35(3):134-7. PubMed ID: 3719709 [No Abstract] [Full Text] [Related]
16. [Promotion mechanism of vascular permeability by Hageman factor]. Yamamoto T Rinsho Byori; 1982 Jun; Suppl 50():114-26. PubMed ID: 7131802 [No Abstract] [Full Text] [Related]
17. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686 [TBL] [Abstract][Full Text] [Related]